A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

NCT07652047 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity & Overweight

Interventions

DRUG: CX11
OTHER: Placebo
DRUG: CX11

Sponsor

Corxel Pharmaceuticals